The Effect of Magnesium on Visual Evoked Potentials in L-NAME-Induced Hypertensive Rats

[1]  Yong Liu,et al.  Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer’s disease mouse model , 2014, Molecular Brain.

[2]  G. Hacioglu,et al.  The relationship between oxidative stress markers and visual evoked potentials in different hypertension models. , 2014, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[3]  G. Tanriover,et al.  The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice , 2014, Neurochemistry International.

[4]  C. Maximino,et al.  Nitric oxide as a regulatory molecule in the processing of the visual stimulus. , 2014, Nitric oxide : biology and chemistry.

[5]  V. Dolinsky,et al.  Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. , 2013, Biochimica et biophysica acta.

[6]  A. Rosanoff,et al.  Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. , 2013, Magnesium research.

[7]  L. Duran,et al.  Therapeutic effect of magnesium sulphate on carbon monoxide toxicity-mediated brain lipid peroxidation. , 2013, European review for medical and pharmacological sciences.

[8]  D. Sharma,et al.  Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension. , 2012, European journal of pharmacology.

[9]  B. Raja,et al.  Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. , 2012, European journal of pharmacology.

[10]  M. Neves,et al.  Magnesium and Vascular Changes in Hypertension , 2012, International journal of hypertension.

[11]  M. Safar,et al.  Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats , 2010, Brain Research.

[12]  Susumu Tonegawa,et al.  Enhancement of Learning and Memory by Elevating Brain Magnesium , 2010, Neuron.

[13]  O. Baskurt,et al.  Effect of exercise training on resistance arteries in rats with chronic NOS inhibition. , 2009, Journal of applied physiology.

[14]  A. Vitale,et al.  Hypertension and the eye , 2008, Current opinion in ophthalmology.

[15]  G. Hacioglu,et al.  The role of docosahexaenoic acid on visual evoked potentials in one kidney-one clip hypertension. , 2006, Acta ophthalmologica Scandinavica.

[16]  M. Ueno,et al.  Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats , 2004, Histochemistry and Cell Biology.

[17]  A. Berthelot,et al.  Effect of Magnesium on mRNA Expression and Production of Endothelin‐1 in DOCA‐Salt Hypertensive Rats , 2003, Journal of cardiovascular pharmacology.

[18]  R. Swaminathan.  Magnesium metabolism and its disorders. , 2003, The Clinical biochemist. Reviews.

[19]  Xi-ru Wu,et al.  Effect of recurrent epileptiform discharges induced by magnesium-free treatment on developing cortical neurons in vitro. , 2003, Brain research. Developmental brain research.

[20]  R. Touyz.  Role of magnesium in the pathogenesis of hypertension. , 2003, Molecular aspects of medicine.

[21]  R. Touyz,et al.  Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species , 2002, Journal of hypertension.

[22]  E. Rock,et al.  Increased phagocytosis and production of reactive oxygen species by neutrophils during magnesium deficiency in rats and inhibition by high magnesium concentration , 2002, British Journal of Nutrition.

[23]  G. Hacioglu,et al.  THE EFFECT OF DIFFERENT HYPERTENSION MODELS ON VISUAL EVOKED POTENTIALS , 2002, The International journal of neuroscience.

[24]  M. Gürbilek,et al.  Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma , 2001, Intensive Care Medicine.

[25]  F. Gündüz,et al.  Tissue and blood levels of zinc, copper, and magnesium in nitric oxide synthase blockade-induced hypertension , 2000, Biological Trace Element Research.

[26]  K. Itoh,et al.  Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension. , 1998, Hypertension research : official journal of the Japanese Society of Hypertension.

[27]  O. P. Tandon,et al.  Visual evoked potentials in primary hypertension. , 1997, Indian journal of physiology and pharmacology.

[28]  F. Dexter,et al.  The Effects of Plasma and Brain Magnesium Concentrations on Lidocaine-Induced Seizures in the Rat , 1996, Anesthesia and analgesia.

[29]  D. Kromhout,et al.  Dietary calcium, potassium, magnesium and blood pressure in the Netherlands. , 1995, International journal of epidemiology.

[30]  H. Vapaatalo,et al.  Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity , 1995, British journal of pharmacology.

[31]  W. Wąsowicz,et al.  Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. , 1993, Clinical chemistry.

[32]  R. Gupta,et al.  Intracellular free magnesium and high energy phosphates in the perfused normotensive and spontaneously hypertensive rat heart. A 31P NMR study. , 1991, American journal of hypertension.

[33]  B. Altura,et al.  Endothelium‐dependent relaxation in coronary arteries requires magnesium ions , 1987, British journal of pharmacology.

[34]  D. Reed,et al.  Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. , 1987, The American journal of clinical nutrition.

[35]  C. E. Wright,et al.  The flash and pattern VEP as a diagnostic indicator of dementia , 1986, Documenta Ophthalmologica.

[36]  J. Lowenstein.  The effects of treatment on target organ damage in hypertensive disease. , 1985, Postgraduate medical journal.

[37]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[38]  D. Rall,et al.  Magnesium exchange between blood and cerebrospinal fluid. , 1963, The American journal of physiology.

[39]  M. Sargon,et al.  Neuroprotective effect of magnesium sulfate and dexamethasone on intrauterine ischemia in the fetal rat brain: ultrastructural evaluation. , 2013, Turkish neurosurgery.

[40]  D. Pojda-Wilczek.  Retrospective analysis of pattern VEP results in different ocular and systemic diseases. , 2010, Klinika oczna.

[41]  P. Tsai,et al.  L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. , 2010, British journal of anaesthesia.

[42]  G. Ravalico,et al.  Antihypertensive drugs and the nervous system: ACE-inhibitors restore oscillatory potentials in hypertensives. , 1999, Clinical and experimental hypertension.

[43]  P. Dodson,et al.  The acute and long-term ocular effects of accelerated hypertension: A clinical and electrophysiological study , 1996, Eye.

[44]  Y. Ohta,et al.  Role of catalase in retinal antioxidant defence system: its comparative study among rabbits, guinea pigs, and rats. , 1996, Ophthalmic Research.

[45]  G. Celesia.  Evoked potential techniques in the evaluation of visual function. , 1984, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.